REPL
Replimune Group Inc
Price:  
11.43 
USD
Volume:  
445,699.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Intrinsic Value

-229.65 %
Upside

Is REPL undervalued or overvalued?

As of 2025-03-19, the Intrinsic Value of Replimune Group Inc (REPL) is -14.82 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 11.43 USD, the upside of Replimune Group Inc is -229.65%. This means that REPL is overvalued by 229.65%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

11.43 USD
Stock Price
-14.82 USD
Intrinsic Value
Intrinsic Value Details

REPL Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -14.82 - -14.82 -14.82 -229.65%
P/E (94.07) - (146.71) (113.96) -1097.0%
DDM - Stable (21.32) - (58.51) (39.92) -449.2%
DDM - Multi (0.33) - (0.68) (0.44) -103.9%

REPL Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 880.22
Beta 1.95
Outstanding shares (mil) 77.01
Enterprise Value (mil) 779.63
Market risk premium 4.60%
Cost of Equity 11.14%
Cost of Debt 5.00%
WACC 10.60%